Results 61 to 70 of about 16,124 (183)
Wanjun Bai,1 Haojing Song,1 Yiting Hu,1 Xueyuan Zhang,2 Xiaoru Wang,3 Caihui Guo,1 Bo Qiu,1 Zhanjun Dong1 1Department of Pharmacy, Hebei General Hospital, Shijiazhuang, Hebei, People’s Republic of China; 2Shanghai Innovstone Therapeutics Limited ...
Hu Y +7 more
core
Background: Antibiotic contamination of aquatic ecosystems, driven by poor waste management, is a critical public and environmental health concern in East Africa, though comprehensive regional data remain limited.
Duresa Dedefo +10 more
doaj +1 more source
Summary Over the past decade, there has been a substantial increase in the diversity and number of therapeutic options for myeloproliferative neoplasms (MPNs). While many remain within the clinical trial arena, the clinician and patient community have seen more approvals reaching the clinic and a rethink on how best we should be approaching these ...
Trung Q. Ngo +3 more
wiley +1 more source
ABSTRACT Aim To characterise the pharmacokinetics (PKs) and safety of BM2216 sustained‐release (SR) tablets after single‐dose oral administration under fasted/fed conditions in healthy participants, assess the effect of food and dose proportionality, and compare the single and multiple‐dose PK of BM2216 SR tablets with mirogabalin besylate tablets to ...
Peiyang Song +6 more
wiley +1 more source
Bioequivalence Evaluation of two formulations of lamotrigine tablets in healthy volunteers
: Lamotrigine is a phenyltriazine used in the treatment of epilepsy and bipolar disorder type I. The purpose of this study was to compare the bioavailability in healthy Colombian volunteers of two brands of lamotrigine 100 mg tablets: a new generic ...
Restrepo Garay, Margarita María +7 more
core +1 more source
Nanocarriers based therapy and diagnosis of brain diseases: cross the blood-brain barrier
The blood-brain barrier (BBB) is the protective interface that isolates the central nervous system from circulating blood, which restricts approximately 98% of small molecule drugs and nearly all large molecules from entering the brain.
Lijun An +11 more
doaj +1 more source
Background The extents of generic-reference and generic-generic average bioequivalence and intra-subject variation of on-market drug products have not been prospectively studied on a large scale.
Muhammad M. Hammami +7 more
doaj +1 more source
Abstract Background Clinical guidelines recommend transfusing ABO‐identical platelets where possible. However, the short shelf life of platelets (5–7 days) and stock availability mean ABO‐nonidentical platelet transfusions are sometimes unavoidable. Minor ABO‐incompatible platelet transfusions carry a risk of hemolysis due to donor anti‐A/B antibodies,
Melanie J. Robbins +5 more
wiley +1 more source
ESTABLISHING POPULATION AND INDIVIDUAL BIOEQUIVALENCE CONFIDENCE INTERVALS [PDF]
Average bioequivalence is used to assess pharmacokinetic properties of proposed generic drug before they are marketed. The limitations of average bioequivalence have led the U.S.
Yu, Feng +5 more
core +1 more source
Background This retrospective analysis aimed to comprehensively review the design and regulatory aspects of bioequivalence trials submitted to the Saudi Food and Drug Authority (SFDA) since 2017.
Turki A. Althunian +15 more
doaj +1 more source

